Literature DB >> 12119304

Klotho protein deficiency leads to overactivation of mu-calpain.

Hiroshi Manya1, Mitsushi Inomata, Toshihiko Fujimori, Naoshi Dohmae, Yuji Sato, Koji Takio, Yo-ichi Nabeshima, Tamao Endo.   

Abstract

The klotho mouse is an animal model that prematurely shows phenotypes resembling human aging. Here we report that in homozygotes for the klotho mutation (kl(-/-)), alpha(II)-spectrin is highly cleaved, even before the occurrence of aging symptoms such as calcification and arteriosclerosis. Because alpha(II)-spectrin is susceptible to proteolysis by calpain, we examined the activation of calpain in kl(-/-) mice. m-Calpain was not activated, but mu-calpain was activated at an abnormally high level, and an endogenous inhibitor of calpain, calpastatin, was significantly decreased. Proteolysis of alpha(II)-spectrin increased with decreasing level of Klotho protein. Similar phenomena were observed in normal aged mice. Our results indicate that the abnormal activation of calpain due to the decrease of Klotho protein leads to degradation of cytoskeletal elements such as alpha(II)-spectrin. Such deterioration may trigger renal abnormalities in kl(-/-) mice and aged mice, but Klotho protein may suppress these processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12119304     DOI: 10.1074/jbc.M206033200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.

Authors:  Ming-Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Makoto Kuro-o; Orson W Moe
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

Review 2.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

3.  Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity.

Authors:  Tetsuro Kusaba; Mitsuhiko Okigaki; Akihiro Matui; Manabu Murakami; Kazuhiko Ishikawa; Taikou Kimura; Kazuhiro Sonomura; Yasushi Adachi; Masabumi Shibuya; Takeshi Shirayama; Shuji Tanda; Tsuguru Hatta; Susumu Sasaki; Yasukiyo Mori; Hiroaki Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-21       Impact factor: 11.205

4.  Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.

Authors:  Tura C Camilli; Mai Xu; Michael P O'Connell; Bonnie Chien; Brittany P Frank; Sarah Subaran; Fred E Indig; Patrice J Morin; Stephen M Hewitt; Ashani T Weeraratna
Journal:  Pigment Cell Melanoma Res       Date:  2010-12-01       Impact factor: 4.693

Review 5.  Klotho and aging.

Authors:  Makoto Kuro-o
Journal:  Biochim Biophys Acta       Date:  2009-02-20

6.  Calpain 10 is required for cell viability and is decreased in the aging kidney.

Authors:  Marisa D Covington; David D Arrington; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

7.  Increased membrane cholesterol might render mature hippocampal neurons more susceptible to beta-amyloid-induced calpain activation and tau toxicity.

Authors:  Alexandra M Nicholson; Adriana Ferreira
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

8.  Morphological mechanism of the development of pulmonary emphysema in klotho mice.

Authors:  Atsuyasu Sato; Toyohiro Hirai; Akihiro Imura; Naoko Kita; Akiko Iwano; Shigeo Muro; Yo-ichi Nabeshima; Bela Suki; Michiaki Mishima
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

Review 9.  Current understanding of klotho.

Authors:  Yuhong Wang; Zhongjie Sun
Journal:  Ageing Res Rev       Date:  2008-10-31       Impact factor: 10.895

10.  Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.

Authors:  Hiroyuki Kadoya; Minoru Satoh; Yoshisuke Haruna; Tamaki Sasaki; Naoki Kashihara
Journal:  Clin Exp Nephrol       Date:  2015-11-19       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.